Literature DB >> 29717790

Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.

Ting Li1, Tao Yu2, Lyu Li3, Lunbo Lu1, Yaoyao Zhuo1, Jingge Lian1, Yun Xiong4, Dexing Kong5, Kangan Li1.   

Abstract

BACKGROUND: Breast MRI is a sensitive imaging technique to assess breast cancer but its effectiveness still remains to be improved.
PURPOSE: To evaluate the diagnostic performance of diffusion-weighted imaging (DWI), diffusion kurtosis imaging (DKI), and quantitative dynamic contrast-enhanced (DCE)-MRI in differentiating malignant from benign breast lesions independently or jointly and to explore whether correlations exist among these parameters. STUDY TYPE: Retrospective. POPULATION: In all, 106 patients with breast lesions (47 malignant, 59 benign). SEQUENCE: DKI sequence with seven b values and quantitative DCE sequence on 3.0T MRI. ASSESSMENT: Diffusion parameters (mean diffusivity [MD], mean diffusivity [MK], and apparent diffusion coefficient [ADC]) from DKI and DWI and perfusion parameters from DCE (Ktrans , kep , ve , and vp ) were calculated by two experienced radiologists after postprocessing. Disagreement between the two observers was resolved by consensus. STATISTICAL TESTS: The parameters in benign and malignant lesions were compared by Student's t-test. The diagnostic performances of DKI and quantitative DCE, either alone or in combination, were evaluated by receiver operating characteristic (ROC) analysis. The Spearman correlation test was used to evaluate correlations among the diffusion parameters and perfusion parameters.
RESULTS: MK, MD, ADC, Ktrans , and kep values were significantly different between breast cancer and benign lesions (P < 0.05). MK from DKI demonstrated the highest AUC of 0.849, which is significantly higher than ADC derived from conventional DWI (z = 3.345, P = 0.0008). The specificity of DCE-MRI-derived parameters was improved when combining diffusion parameters, such as ADC and MK. The highest diagnostic specificity (93.2%) was obtained when kep and ADC were combined. kep was correlated moderately positively with MK (r = 0.516) and moderately negatively with MD (r = -0.527). Ktrans was weakly positively correlated with MK with an r of 0.398 and weakly negatively correlated with MD with an r of -0.450. DATA
CONCLUSION: DKI is more valuable than conventional DWI in distinguishing between benign and malignant breast lesions. DKI exhibits promise as a quantitative technique to augment quantitative DCE-MRI. Diffusion parameters derived from DKI were statistically correlated with perfusion parameters from quantitative DCE-MRI. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:1358-1366.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  breast; diagnosis; diffusion; magnetic resonance imaging; neoplasms

Mesh:

Substances:

Year:  2018        PMID: 29717790     DOI: 10.1002/jmri.26059

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  9 in total

1.  Diffusional kurtosis imaging for differentiation of additional suspicious lesions on preoperative breast MRI of patients with known breast cancer.

Authors:  Vivian Youngjean Park; Sungheon G Kim; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon; Min Jung Kim
Journal:  Magn Reson Imaging       Date:  2019-07-16       Impact factor: 2.546

Review 2.  Current and Emerging Magnetic Resonance-Based Techniques for Breast Cancer.

Authors:  Apekshya Chhetri; Xin Li; Joseph V Rispoli
Journal:  Front Med (Lausanne)       Date:  2020-05-12

3.  Diffusion-weighted imaging and diffusion kurtosis imaging for early evaluation of the response to docetaxel in rat epithelial ovarian cancer.

Authors:  Su-Juan Yuan; Tian-Kui Qiao; Jin-Wei Qiang
Journal:  J Transl Med       Date:  2018-12-05       Impact factor: 5.531

4.  Impact of Alternate b-Value Combinations and Metrics on the Predictive Performance and Repeatability of Diffusion-Weighted MRI in Breast Cancer Treatment: Results from the ECOG-ACRIN A6698 Trial.

Authors:  Savannah C Partridge; Jon Steingrimsson; David C Newitt; Jessica E Gibbs; Helga S Marques; Patrick J Bolan; Michael A Boss; Thomas L Chenevert; Mark A Rosen; Nola M Hylton
Journal:  Tomography       Date:  2022-03-04

Review 5.  Diagnostic Performance of Diffusion Kurtosis Imaging for Benign and Malignant Breast Lesions: A Systematic Review and Meta-Analysis.

Authors:  Hongyu Gu; Wenjing Cui; Song Luo; Xiaoyi Deng
Journal:  Appl Bionics Biomech       Date:  2022-06-09       Impact factor: 1.664

6.  Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma.

Authors:  Alan W L Mui; Anne W M Lee; W T Ng; Victor H F Lee; Varut Vardhanabhuti; Shei S Y Man; Daniel T T Chua; X Y Guan
Journal:  Phys Imaging Radiat Oncol       Date:  2022-09-12

7.  Preliminary study on identification of estrogen receptor-positive breast cancer subtypes based on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) texture analysis.

Authors:  Hui Wang; Yunting Hu; Hui Li; Yuanliang Xie; Xiang Wang; Weijia Wan
Journal:  Gland Surg       Date:  2020-06

8.  Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial.

Authors:  Elizabeth S McDonald; Justin Romanoff; Habib Rahbar; Averi E Kitsch; Sara M Harvey; Jennifer G Whisenant; Thomas E Yankeelov; Linda Moy; Wendy B DeMartini; Basak E Dogan; Wei T Yang; Lilian C Wang; Bonnie N Joe; Lisa J Wilmes; Nola M Hylton; Karen Y Oh; Luminita A Tudorica; Colleen H Neal; Dariya I Malyarenko; Christopher E Comstock; Mitchell D Schnall; Thomas L Chenevert; Savannah C Partridge
Journal:  Radiology       Date:  2020-11-17       Impact factor: 11.105

9.  Influence of residual fat signal on diffusion kurtosis MRI of suspicious mammography findings.

Authors:  Anna Mlynarska-Bujny; Sebastian Bickelhaupt; Frederik Bernd Laun; Franziska König; Wolfgang Lederer; Heidi Daniel; Mark Edward Ladd; Heinz-Peter Schlemmer; Stefan Delorme; Tristan Anselm Kuder
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.